Loading...
Indian Pharmaceutical Exporter · #6 for Metformin · $14.8M export value · DGFT Verified
Aurobindo Pharma Ltd is the #6 Indian exporter of Metformin with $14.8M in export value and 296 verified shipments. Aurobindo Pharma Ltd holds a 3.2% market share in Metformin exports across 9 countries.
| $1.3M |
| 43 |
| 5.3% |
| UNITED STATES | $1.1M | 86 | 4.7% |
| UNITED STATES OF AMERICA | $728.4K | 15 | 3.0% |
| ISRAEL | $418.3K | 25 | 1.7% |
| IRELAND | $162.2K | 10 | 0.7% |
| FINLAND | $114.8K | 3 | 0.5% |
Aurobindo Pharma Ltd exports Metformin to 12 countries. The largest destination is MALTA accounting for 30.0% of Aurobindo Pharma Ltd's Metformin shipments, followed by CANADA (27.2%) and FRANCE (18.7%). These destinations reflect Aurobindo Pharma Ltd's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| APL SWIFT SERVICES (MALTA) LTD., | MALTA | $4.9M | 465 |
| ARROW GENERIQUES, | FRANCE | $3.1M | 186 |
| AURO PHARMA INC | CANADA | $2.6M | 144 |
| AURO PHARMA INC, | CANADA | $2.5M | 75 |
| ARROW GENERIQUES | FRANCE | $1.2M | 60 |
| APL SWIFT SERVICES MALTA LIMITED | MALTA | $909.1K | 74 |
| XXROBXXDO XXARMXXUSAXXNC | UNITED STATES OF AMERICA | $728.4K | 15 |
| BIOTON S A MAGAZYN CENTRALNYUL MACIERZYSZ UL | POLAND | $618.3K | 20 |
| AURO PHARMA INC C O LYNDEN | CANADA | $571.1K | 13 |
| APL SWIFT SERVICES MALTA LTD | MALTA | $528.4K | 33 |
Aurobindo Pharma Ltd supplies Metformin to 69 buyers globally. The largest buyer is APL SWIFT SERVICES (MALTA) LTD., (MALTA), followed by ARROW GENERIQUES, (FRANCE) and AURO PHARMA INC (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $266.5M worth of Metformin through 15,000 shipments from 528 suppliers to 160 countries, serving 1,475 buyers globally. Aurobindo Pharma Ltd contributes $14.8M to this total, accounting for 3.2% of India's Metformin exports. Aurobindo Pharma Ltd ships Metformin to 12 countries through 69 buyers.
Aurobindo Pharma Ltd's average Metformin shipment value is $50.0K per consignment, based on 296 shipments totaling $14.8M. The largest destination is MALTA (30.0% of Aurobindo Pharma Ltd's Metformin exports).
Aurobindo Pharma Ltd ranks #6 among 528 Indian Metformin exporters with a 3.2% market share. The top 3 exporters are GRANULES INDIA LIMITED ($113.9M), ZENTIVA PRIVATE LIMITED ($19.4M), IPCA LABORATORIES LIMITED ($17.1M). Aurobindo Pharma Ltd processed 296 shipments to 9 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| METFORMIN TABLETS 500MG(AURO-METFORMIN 5 | $1.3M | 31 |
| GLYBURIDE AND METFORMIN HYDROCHLORIDE TA | $541.1K | 33 |
| METFORMIN TABLETS 500MG(METFORMIN AUROBI | $453.6K | 14 |
| METFORMIN 1000 MG TABLETS(Metformina Gen | $423.3K | 15 |
| METFORMIN TABLETS 850MG (Metformine Arro | $408.2K | 17 |
| METFORMIN 1000 MG TABLETS(Metformine Arr | $402.4K | 16 |
| METFORMIN TABLETS 500MG(Metformina Gener | $386.8K | 9 |
| METFORMIN 1000 MG TABLETS(Metformine HCl | $310.5K | 12 |
| METFORMIN TABLETS 500MG(Metformine Arrow | $301.0K | 12 |
| METFORMIN TABLETS 500 MG 1000'S PACK | $300.0K | 6 |
Aurobindo Pharma Ltd exports 677 distinct Metformin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is METFORMIN TABLETS 500MG(AURO-METFORMIN 5 with 31 shipments worth $1.3M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
What Aurobindo Pharma Ltd must comply with to export Metformin to its top destination countries
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | INVENTIA HEALTHCARE LIMITED | $16.4M | 329 | 16 | $50.0K |
| 7 | MICRO LABS LIMITED | $16.2M | 552 | 31 | $29.4K |
| 6 | AUROBINDO PHARMA LTD ★ | $14.8M | 296 | 9 | $50.0K |
| 8 | ALKEM LABORATORIES LIMITED | $13.3M | 289 | 4 | $45.9K |
| 9 | ZYDUS LIFESCIENCES LIMITED | $9.8M | 196 | 8 | $50.0K |
Aurobindo Pharma Ltd ranks #6 among 528 Indian Metformin exporters. Average shipment value of $50.0K compared to the market average of $504.7K. The closest competitors by value are INVENTIA HEALTHCARE LIMITED and MICRO LABS LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 2,284 | 15.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,638 | 10.9% |
| HYDERABAD ICD (INSNF6) | 1,593 | 10.6% |
| DELHI AIR CARGO ACC (INDEL4) | 1,355 | 9.0% |
| SAHAR AIR | 1,015 | 6.8% |
| JNPT/ NHAVA SHEVA SEA | 843 | 5.6% |
| DELHI AIR | 711 | 4.7% |
| Bombay Air | 695 | 4.6% |
Latest developments and market context
Detailed market intelligence for Metformin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 160+ countries, 1,475+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Ltd's Metformin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Ltd
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Metformin. For current shipment-level data, contact TransData Nexus.